Cabarrou, Bastien
Gomez-Roca, Carlos
Viala, Marie
Rabeau, Audrey
Paulon, Rodolphe
Loirat, Delphine
Munsch, Nadia
Delord, Jean-Pierre
Filleron, Thomas
Funding for this research was provided by:
Bristol-Myers Squibb Foundation (Bristol-Myers Squibb Foundation for Research in Immuno-Oncology)
Article History
Received: 17 March 2020
Accepted: 7 April 2020
First Online: 7 May 2020
Compliance with ethical standards
:
: Bastien Cabarrou declares that he has no conflict of interest. Carlos Gomez-Roca declares Institutional Research Funding, Honoraria and Travel grant by BMS. Marie Viala declares that she has no conflict of interest. Audrey Rabeau declares that she has no conflict of interest. Rodolphe Paulon declares that he has no conflict of interest. Delphine Loirat declares Honoraria and Travel grant by BMS, MSD and Roche. Nadia Munsch declares that she has no conflict of interest. Jean-Pierre Delord declares Institutional Research Funding by Genentech, BMS and MSD Oncology and has a consulting or advisory role for Novartis, Roche/Genentech, BMS and MSD Oncology. Thomas Filleron declares that he has no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, formal consent is not required.